ADDvise signs Letter of Intent to acquire Innovative Endoscopy Components, LLC.

15-06-2023   Regulatory press release

ADDvise has signed a Letter of Intent with the shareholders of Innovative Endoscopy Components, LLC. (”IEC”) regarding an acquisition of all shares in IEC.

IEC is an international provider of endoscopy equipment and endoscopy spare parts based in Fort Lauderdale, Florida, USA. The company manufactures, supplies and repairs OEM and aftermarket parts to the endoscopy industry with customers in over 100 countries.

The company’s revenue for the last twelve months as of May 31, 2023 amounted to USD 9.4 million with an EBITDA of USD 1.7 million, corresponding to an EBITDA margin of 18.4 percent.

The purchase price for IEC amounts to an initial payment of USD 8.25 million, and two potential earn-outs of USD 1.75 million in total.

The acquisition will be financed with own funds and existing credit facilities. ADDvise assesses that the acquisition will have a positive impact on ADDvise earnings per share for the financial year 2023.

The acquisition is subject to a due diligence and that the parties agree to enter into a share purchase agreement. The acquisition is expected to be completed during the second half of 2023.

The previously communicated Letter of Intents to acquire Reina and Diabetic Supplies are expected to be completed during the third quarter 2023.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on June 15, 2023, at 16:20 CEST.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,,is the Company's Certified Adviser. Additional information is available at



Latest press releases

ADDvise Group’s CEO divests shares - remains a committed and long-term shareholder


Rikard Akhtarzand, CEO of ADDvise Group AB (publ) (“ADDvise” or the “Company”), has informed the Company that he has sold 2,500,000 Class B shares in ADDvise, representing approximately 1.3% of total outstanding shares and 18.1% of his total shareholding in the Company, and that he has entered a 180-day lock-up agreement for his remaining shares.…

ADDvise acquires Diabetic Supplies Inc.


ADDvise Group has today entered into a share purchase agreement with the owners of Diabetic Supplies Inc. (“Diabetic Supplies”) regarding the acquisition of all shares of Diabetic Supplies in accordance with the letter of intent previously communicated. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue…

ADDvise receives order worth USD 4 million


ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Tecnimont. The order involves the design endorsement, supply, and installation of multiple cleanroom facilities as part of a larger industrial project. The order is worth approximately USD 4 million. Tecnimont, a subsidiary of Maire, is a leading integrated engineering and construction services and…

ADDvise Group recruits Oliver Humlen as new CFO


ADDvise recruits Oliver Humlen as new CFO and member of the executive management team. Oliver has more than a decade of experience from investment banking. He joins ADDvise from Pareto Securities where he has been working within Debt Capital Markets for the past nine years, of which six as Partner. Prior to that, he worked…